Research and analysis

Breast screening: Hologic Affirm DBT biopsy system

This report describes a practical evaluation of the Hologic Affirm digital breast tomosynthesis biopsy system in NHS breast screening.

• From: Public Health England
• Published: 30 December 2015

This publication was withdrawn on 2 July 2021

These reports are now available from the National Co-ordinating Centre for the Physics of Mammography (NCCPM).

Documents

[Withdrawn] Practical evaluation of Hologic Affirm digital breast tomosynthesis biopsy system

Ref: PHE publications gateway number 2015570

PDF, 3.96 MB, 62 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The overall objective of the evaluation was to evaluate the clinical performance of tomosynthesis biopsy using the Hologic Selenia Dimensions and the Hologic Affirm breast biopsy guidance system, and to evaluate the associated technical issues.

The detailed objectives were to:

• evaluate the usefulness of the Affirm tomosynthesis biopsy system as part of the assessment process
• assess the practical aspects of use and report on the operators’ views and experience
• assess the performance and reliability of the equipment when in use for tomosynthesis biopsies
• report on radiation dose to the breast from imaging during tomosynthesis biopsy

Published 30 December 2015